Clinical Trials in Michigan

Showing 8501-8520 of 12,290 trials

TARGET Intracranial Aneurysm Coiling Registry

NCT01748903

The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.

Intracranial Aneurysms

Mercy Health Ohio150 participantsStarted Feb 2013

Phoenix, Arizona, United States • Tallahassee, Florida, United States • Joliet, Illinois, United States +6 more locations

TERMINATEDPhase 162 miles

Study of Samalizumab in Patients With Advanced Cancer

NCT02987504

This is a multicenter, open-label, dose-escalation, Phase 1 study of intravenous (IV) samalizumab to determine its maximum tolerated dose (MTD), overall safety/tolerability, pharmacokinetic and pharmacodynamic parameters, and efficacy in participants with advanced cancer. The study was terminated for administrative reasons and not due to any safety concerns.

Advanced Solid Tumors

Alexion Pharmaceuticals, Inc.10 participantsStarted Nov 2016

New Haven, Connecticut, United States • Grand Rapids, Michigan, United States • San Antonio, Texas, United States

TARGET Intracranial Aneurysm Coiling Registry

Study of Samalizumab in Patients With Advanced Cancer

Find Trials by Condition in Michigan

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Eslicarbazepine Acetate Monotherapy Long Term Study

Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps

Open Label Study of Long Term Safety Evaluation of Alirocumab

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis